Podcasts about honorary consultant neurologist

In this special extended podcast we have three guests in our virtual studio to examine whether we're getting the messaging about Parkinson's right, be it reporting research findings or at a patient appointment.  With the help of Prof David Dexter, Director of Research at Parkinson's UK and Professor of Neuropharmacology at Imperial College London, Dr Angus Macleod, Honorary Consultant Neurologist at NHS Grampian and Clinical Senior Lecturer at the University of Aberdeen, and former broadcast and print journalist Iain Stephen Morrison, who is the Media and Communications Officer for Parkinson's UK in Scotland, we discuss the difficulties of painting a realistic picture whilst remaining mindful of feelings and still preserving hope. We tackle some difficult topics including prognosis and the mixed messaging surrounding whether one dies with or from Parkinson's, and examine bias in research participation, publicity and public awareness campaigns. 

This episode focuses on the remarkable research being done by Dr Tom Gilbertson in Dundee, that suggests people with Parkinson's may be able to reprogram new pathways in their brain to overcome the common symptom of apathy. He also describes his future work and the belief that non-invasive, reversible ultrasound therapies may one day be capable of modifying the function of neurons to provide symptom control.  

Dr Angus Macleod is a Honorary Consultant Neurologist with NHS Grampian specialising in movement disorders inc. Parkinson's and also a Senior Lecturer at the School of Medicine at the University of Aberdeen. This podcast focuses on his own research and also his views on the most promising areas of research currently underway.  The North of Scotland Parkinsons research interest groups:  https://www.nosprig.org/ Research groups nationally:  https://www.parkinsons.org.uk/research/local-parkinsons-research-interest-groups Parkinson's UK Scotland:  https://www.parkinsons.org.uk/about-us/parkinsons-uk-scotland  

Atypical Parkinsonian Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies are often initially diagnosed as Parkinson's disease. Incorrect, incomplete, or delayed diagnoses are barriers to beginning the most appropriate treatment early in the disease course. More research is needed to facilitate early diagnoses, understanding of disease pathogenesis, and monitoring of disease progression. However, largescale, collaborative initiatives are making meaningful progress in understanding genetic contributors to disease pathology and progression in Parkinson's disease. Our guest in this episode, Dr. Huw Morris, has spent more than twenty five years researching Parkinson's disease and parkinsonian syndromes, and he shares highlights from recent work, including studies on the genetics and pathogenesis of Parkinson's disease and other parkinsonian syndromes. Huw is Professor of Clinical Neuroscience at University College London Institute of Neurology, as well as an Honorary Consultant Neurologist at the Royal Free Hospital and the National Hospital for Neurology and Neurosurgery Queen Square. This podcast is geared toward researchers and clinicians. If you live with Parkinson's or have a friend or family member with PD, listen to The Michael J. Fox Foundation Parkinson's Podcast. Hear from scientists, doctors and people with Parkinson's on different aspects of life with the disease as well as research toward treatment breakthroughs at https://www.michaeljfox.org/podcasts.

Atypical Parkinsonian Syndromes, such as progressive supranuclear palsy (PSP), multiple system atrophy (MSA), corticobasal degeneration (CBD), and dementia with Lewy bodies are often initially diagnosed as Parkinson's disease. Incorrect, incomplete, or delayed diagnoses are barriers to beginning the most appropriate treatment early in the disease course. More research is needed to facilitate early diagnoses, understanding of disease pathogenesis, and monitoring of disease progression. However, largescale, collaborative initiatives are making meaningful progress in understanding genetic contributors to disease pathology and progression in Parkinson's disease. Our guest in this episode, Dr. Huw Morris, has spent more than twenty five years researching Parkinson's disease and parkinsonian syndromes, and he shares highlights from recent work, including studies on the genetics and pathogenesis of Parkinson's disease and other parkinsonian syndromes. Huw is Professor of Clinical Neuroscience at University College London Institute of Neurology, as well as an Honorary Consultant Neurologist at the Royal Free Hospital and the National Hospital for Neurology and Neurosurgery Queen Square. This podcast is geared toward researchers and clinicians. If you live with Parkinson's or have a friend or family member with PD, listen to The Michael J. Fox Foundation Parkinson's Podcast. Hear from scientists, doctors and people with Parkinson's on different aspects of life with the disease as well as research toward treatment breakthroughs at https://www.michaeljfox.org/podcasts.

Dr Angus Macleod is a Honorary Consultant Neurologist with NHS Grampian specialising in movement disorders inc. Parkinson's and also a Senior Lecturer at the School of Medicine at the University of Aberdeen. This podcast focuses on his own research and also his views on the most promising areas of research currently underway.  The North of Scotland Parkinsons research interest groups:  https://www.nosprig.org/ Research groups nationally:  https://www.parkinsons.org.uk/research/local-parkinsons-research-interest-groups Parkinson's UK Scotland:  https://www.parkinsons.org.uk/about-us/parkinsons-uk-scotland  

Sarah Tabrizi is Director of the UCL Huntington's Disease (HD) Centre, Joint Head of Department Neurodegenerative Disease at the UCL Queen Square Institute of Neurology, a Principal Investigator at the UK Dementia Research Institute, and Honorary Consultant Neurologist at the National Hospital for Neurology and Neurosurgery. She graduated in Biochemistry, then studied Medicine at the University of Edinburgh where she was awarded the 1992 Leslie Gold Medal for the most distinguished medical graduate. Sarah undertook her PhD and trained as an independent scientist at UCL, establishing a large basic bench science and translational research team focussed on finding disease modifying therapies for HD. She was PI on the first successful phase 1/2b trial of an antisense oligonucleotide (NEJM 2019) and currently serves on several SABs advising industry on the development of potential gene targeting and nucleic acid therapies for HD. Sarah has published over 350 peer-reviewed research papers. In 2014 she was elected as a Fellow of the UK Academy of Medical Sciences. In 2017 she received the seventh Leslie Gehry Brenner Prize for Innovation in Science awarded by the Hereditary Disease Foundation. In 2018 she received the Cotzias Award from the Spanish Society of Neurology, and in 2019 the Yahr Award at the World Congress for Neurology and the Alexander Morison Medal from the Royal College of Physicians of Edinburgh. In 2022, she received the Osler Medal from the Association of Physicians of Great Britain and Ireland.

We are delighted to welcome back Professor Benedict Michael to The Encephalitis Podcast. Ben talks to host Dr Ava Easton about the COVID-19 Clinical Neuroscience Study – a £2.3 million research study looking in the acute neurological and neuropsychiatric complications of COVID-19. He also shares his thoughts on being a front-line medic during the pandemic, the NHS in general and the upcoming Encephalitis Conference. Ben is a Professor of Neuroscience at the University of Liverpool, a Medical Research Council Clinician Scientist and Honorary Consultant Neurologist at the Walton Centre, also in Liverpool. Ben is also Vice President of our Scientific Advisory Panel and helps to drive forward our research agenda and organise the Encephalitis Conference, among many other important areas of our work. For more about the COVID-CNS study or to take part, visit https://www.liverpool.ac.uk/covid-clinical-neuroscience-study/ Follow the COVID-CNS study on Twitter: https://twitter.com/covidcns Follow Ben on Twitter: https://twitter.com/BenedictNeuro If you have been affected by encephalitis and are in need of some support, please visit https://www.encephalitis.info/support If you have been affected by encephalitis and would like to become a member of the society, you can sign up here (membership is free and global): https://www.encephalitis.info/Pages/Category/membership If you would like to donate to help fund research, information and support for those affected by encephalitis, please follow this link: https://www.encephalitis.info/donate/donate/10 Follow the Encephalitis Society: Facebook: https://www.facebook.com/EncephalitisSociety/ Twitter: https://twitter.com/encephalitis Instagram: https://www.instagram.com/the_encephalitis_society_/ LinkedIn: https://www.linkedin.com/company/the-encephalitis-society  

Dr Jonathan Bardgett interviews Dr David Breen about Parkinson's Disease. How PD is diagnosed, and discussion of different therapies used to treat, therapies to avoid, and side-effects of medications. Dr Breen is a Senior Clinical Research Fellow at the University of Edinburgh and Honorary Consultant Neurologist at NHS Lothian. He completed neurology and research training in Cambridge and London, before moving to Toronto as a post-CCT Movement Disorders Fellow. He specialises in the assessment and treatment of people with all types of movement disorders.

Australian-born Professor Peter Goadsby is the NIHR-Wellcome Trust King's Clinical Research Facility at King's College London in the United Kingdom and is Professor of Neurology at the University of California, Los Angeles, USA. He is also Honorary Consultant Neurologist at King's College Hospital and the Hospital for Sick Children, Great Ormond St, London. Professor Goadsby is one of four neuroscientists who have won this year's prestigious international Brain Prize. The group has been recognised for discovering a key mechanism that causes migraines. Dr Deborah Devis, a science journalist with the Royal Institution of Australia,  talks to Professor Goadsby about the culmination of four decades of developing new classes of migraine-specific drugs that are informed by the neurology of the brain.Find the science of everything at cosmosmagazine.com

Anne Rosser is Professor of Clinical Neuroscience at Cardiff University and Honorary Consultant Neurologist at the University Hospital of Wales. She trained in Medicine at Cambridge University where she also undertook her PhD in Neuroscience. She has worked in the area of neurodegeneration since 1994 and has a special interest in Huntington’s disease (HD), in particular the development of new therapies for this and related neurodegenerative conditions. She directs the Cardiff University Brain Repair Group; leads the South Wales HD clinical service; and co-directs the Wales Brain Repair and Intracranial Neurotherapeutics (BRAIN) Unit, which aims to deliver therapeutics into the brain in neurological conditions. She led the FP7 Consortium Repair-HD between 2013 and 2018, and is currently Chair of the European HD Network. Dr. Patrick Weydt is a board certified neurologist and certified neurogenetic counselor in the Department of Neurodegenerative Diseases and Gerontopsychiatry where he heads the Huntington’s Disease Clinic.  He has been involved in several studies and clinical trials for Huntington's disease, including LEGATO, PREDICT, REGISTRY and most recently ASO in HD. He has served as a member of the Scientific and Bioethical Advisory Board for EHDN and is currently the Co-Chair of the European HD Network.

Professor Tipu Aziz and Dr Binith Cheeran talk about deep brain stimulation (DBS) for treating intractable pain syndromes. Professor Halliday is Professor of Neurosurgery at the Nuffield Department of Surgical Sciences and Dr Cheeran is an Honorary Consultant Neurologist at the Nuffield Department of Clinical Neurosciences at the University of Oxford.

Chis Butler, MRC Clinician Scientist and Honorary Consultant Neurologist at the University of Oxford, talks to Jessica Eccles, MRC Clinical Research Training Fellow, Brighton and Sussex Medical School, about her work into joint hypermobilty and autonomic hyperactivity, and their relevance to neurodevelopmental disorders. Read the abstract: http://jnnp.bmj.com/content/85/8/e3.40.abstract This podcast was recorded at the 2014 British NeuroPsychiatry Association AGM.

Chris Butler, MRC Clinician Scientist and Honorary Consultant Neurologist at the University of Oxford, talks to Catherine Slattery, Clinical Research Associate, Institute of Neurology, about her work looking at TREM2 and associated risk of dementia. Read the abstract: http://goo.gl/SkJVXr This podcast was recorded at the 2014 British NeuroPsychiatry Association AGM.